Flow cytometry and scRNAseq analyses demonstrated that systemic IRE1α inhibition increased MHC-I heavy-chain transcript and surface-protein levels in tumor-infiltrating DCs, mirroring the in vitro BMDC experiments. This evidence concerns the gene ERN1 and neoplasm.